Mar 18, 2020- The test will be used on the company's m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.- Abbott shipping 150,000 laboratory tests immediately; tests already sent to hospital and academic medical center labs in 18 states including Illinois, California, New York, Massachusetts and Washington- Company scaling up production at its U.S. manufacturing location to reach capacity for 1 million tests per week by end of March
Mar 5, 2020- New FlexNav™ delivery system improves control and delivery of the Portico™ TAVI valve even in complex clinical cases- The minimally invasive Portico procedure allows doctors to treat severe aortic valve stenosis without invasive surgery- Approval of the new delivery system follows first implants of the company's next-generation and investigational Navitor™ TAVI valve- Feb 20, 2020- Data at ATTD reinforce and add to a growing body of clinical research and real-world evidence from users of the FreeStyle Libre system around the world- People in Germany living with Type 1 or Type 2 diabetes on insulin showed a sustained reduction in HbA1c over one year following use of the FreeStyle Libre technology
Feb 19, 2020- Collaboration will combine Abbott's leading continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon™ Automated Insulin Delivery System to offer an accurate, easy-to-use, integrated digital health platform- Integrated technology will provide people living with diabetes around the world an affordable, transformational experience for improved glucose control- Feb 18, 2020- New Gallant™ high voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity designed to help doctors tailor therapy to a patient's unique clinical needs- Gallant ICD and CRT-D devices feature a more comfortable design, preferred by patients without compromising on battery longevity or high-voltage output, which remain among the highest in the industry